Back
Aytu Biopharma, Inc. 10K Form
Sell
46
AYTU
Aytu Biopharma, Inc.
Last Price:
$2.57
Seasonality Move:
-20.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AYTU News And Ratings
See the #1 stock for the next 7 days that we like better than AYTU
AYTU Financial Statistics
Sales & Book Value
| Annual Sales: | $66.4M |
|---|---|
| Cash Flow: | $-618K |
| Price / Cash Flow: | 28.82 |
| Annual Sales: | $2.34 |
| Price / Book: | 1.12 |
Profitability
| EPS (TTM): | -3.04670 |
|---|---|
| Net Income (TTM): | $-13.3M |
| Gross Margin: | $42.1M |
| Return on Equity: | -48.36% |
| Return on Assets: | -10.99% |
Aytu Biopharma, Inc. Earnings Forecast
Key Aytu Biopharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 21 years for AYTU is 63.49%.
-
The Selling, General & Administrative Expenses for AYTU have been equal to 57.67% of Gross Profit Margin.
-
The Research & Development expenses have been 2.00% of Revenue.
-
The Net Earning history of AYTU is -21.36% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 9 years.
Aytu Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AYTU |
| CUSIP: | 054754 |
| Website: | aytubio.com |
Debt
| Debt-to-Equity Ratio: | 1.23 |
|---|---|
| Current Ratio: | 1.23 |
| Quick Ratio: | 1 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 15 |
AYTU Technical Analysis vs Fundamental Analysis
Sell
46
Aytu Biopharma, Inc. (AYTU)
is a Sell
Is Aytu Biopharma, Inc. a Buy or a Sell?
-
Aytu Biopharma, Inc. stock is rated a SellThe current Aytu Biopharma, Inc. [AYTU] share price is $2.55. The Score for AYTU is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.